Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Pol

Showing results (281-290 of 441) with videos related to

Pageof 45
Sort By:
BMC Medicine|May 4, 2017
Late presentation of chronic viral hepatitis for medical care: a consensus definitionStefan Mauss, Stanislas Pol, Maria Buti, et al.
Cannabis and Cannabinoid Research|October 14, 2021
Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort)Tangui Barré, Stanislas Pol, Clémence Ramier, et al.
JHEP Reports : Innovation in Hepatology|January 3, 2022
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosisPierre Nahon, Marie Najean, Richard Layese, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 2, 2018
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia VasculitisPatrice Cacoub, Si Nafa Si Ahmed, Yasmina Ferfar, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapyFirouzé Bani-Sadr, Fabrice Carrat, Stanislas Pol, et al.
AIDS (London, England)|June 5, 2007
Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)Lionel Piroth, Damien Sène, Stanislas Pol, et al.
Science Advances|May 7, 2025
Structural basis for hepatitis E virus neutralization by potent human antibodiesLuis M Molinos-Albert, Eduard Baquero, Cyril Planchais, et al.
Journal of Viral Hepatitis|August 19, 2020
Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort)Tangui Barré, Marie Libérée Nishimwe, Camelia Protopopescu, et al.
Pharmacoepidemiology and Drug Safety|November 29, 2022
Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancersLaurent Lam, Hélène Fontaine, Nathanael Lapidus, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 16, 2023
Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)Patrizia Carrieri, Marc Bourlière, Vincent Di Beo, et al.
Pageof 45

Showing results (281-290 of 441) with videos related to

Sort By:
Pageof 45
BMC Medicine|May 4, 2017
Late presentation of chronic viral hepatitis for medical care: a consensus definitionStefan Mauss, Stanislas Pol, Maria Buti, et al.
Cannabis and Cannabinoid Research|October 14, 2021
Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort)Tangui Barré, Stanislas Pol, Clémence Ramier, et al.
JHEP Reports : Innovation in Hepatology|January 3, 2022
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosisPierre Nahon, Marie Najean, Richard Layese, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 2, 2018
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia VasculitisPatrice Cacoub, Si Nafa Si Ahmed, Yasmina Ferfar, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapyFirouzé Bani-Sadr, Fabrice Carrat, Stanislas Pol, et al.
AIDS (London, England)|June 5, 2007
Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)Lionel Piroth, Damien Sène, Stanislas Pol, et al.
Science Advances|May 7, 2025
Structural basis for hepatitis E virus neutralization by potent human antibodiesLuis M Molinos-Albert, Eduard Baquero, Cyril Planchais, et al.
Journal of Viral Hepatitis|August 19, 2020
Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort)Tangui Barré, Marie Libérée Nishimwe, Camelia Protopopescu, et al.
Pharmacoepidemiology and Drug Safety|November 29, 2022
Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancersLaurent Lam, Hélène Fontaine, Nathanael Lapidus, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 16, 2023
Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)Patrizia Carrieri, Marc Bourlière, Vincent Di Beo, et al.
Pageof 45